PRJNA207719: Tissue specific transcriptome profiling
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
irf2 | dr11_v1_chr14_-_4121052_4121052 | 0.93 | 2.1e-02 | Click! |
irf1b | dr11_v1_chr21_+_45627775_45627775 | 0.81 | 9.7e-02 | Click! |
irf2a | dr11_v1_chr1_+_39865748_39865753 | -0.61 | 2.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_-_22648007 Show fit | 7.79 |
ENSDART00000121788
|
grass carp reovirus (GCRV)-induced gene 2l |
|
chr19_-_7115229 Show fit | 6.78 |
ENSDART00000001930
|
proteasome subunit beta 13a |
|
chr19_+_7115223 Show fit | 4.96 |
ENSDART00000001359
|
proteasome subunit beta 12 |
|
chr16_+_23487051 Show fit | 4.87 |
ENSDART00000145496
|
ictacalcin 2 |
|
chr11_-_20096018 Show fit | 4.63 |
ENSDART00000030420
|
opioid growth factor receptor-like 2 |
|
chr3_-_60316118 Show fit | 4.58 |
ENSDART00000171458
|
si:ch211-214b16.2 |
|
chr13_+_13681681 Show fit | 4.52 |
ENSDART00000057825
|
complement factor D (adipsin) |
|
chr9_-_45601103 Show fit | 4.23 |
ENSDART00000180465
|
anterior gradient 1 |
|
chr12_-_4388704 Show fit | 4.18 |
ENSDART00000152168
|
si:ch211-173d10.1 |
|
chr5_+_13373593 Show fit | 4.17 |
ENSDART00000051668
ENSDART00000183883 |
chemokine (C-C motif) ligand 19a, tandem duplicate 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 18.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 9.9 | GO:0051607 | defense response to virus(GO:0051607) |
0.9 | 8.7 | GO:1900407 | regulation of cellular response to oxidative stress(GO:1900407) |
0.0 | 8.1 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 6.7 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.2 | 6.2 | GO:0071346 | response to interferon-gamma(GO:0034341) cellular response to interferon-gamma(GO:0071346) |
0.1 | 6.0 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) positive regulation of peptidase activity(GO:0010952) |
0.1 | 4.6 | GO:0009612 | response to mechanical stimulus(GO:0009612) |
1.5 | 4.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 4.4 | GO:0031101 | fin regeneration(GO:0031101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 19.1 | GO:0005615 | extracellular space(GO:0005615) |
0.7 | 18.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 17.9 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 12.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 9.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 6.5 | GO:0000785 | chromatin(GO:0000785) |
0.5 | 4.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.0 | 3.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 2.9 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 2.8 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 26.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.4 | 20.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 14.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 12.0 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 10.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 8.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 7.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 6.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 4.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 4.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 3.6 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 3.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 2.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 2.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 10.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 6.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 5.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 5.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 3.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 3.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 2.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 1.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 1.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |